Brentuximab vedotin containing salvage followed by consolidation post autologous hematopoietic stem cell transplantation in high risk relapsed refractory classical Hodgkin lymphoma

Moussab Damlaj; Khadega A Abuelgasim; Ayman Alhejazi; Bader Alahmari; Ahmed Alaskar; Mohsen Alzahrani

doi:10.1038/s41409-020-0935-0

$Brentuximab vedotin containing salvage followed by consolidation post autologous hematopoietic stem cell transplantation in high risk relapsed refractory classical Hodgkin lymphoma$

Journal article

Peer reviewed

Brentuximab vedotin containing salvage followed by consolidation post autologous hematopoietic stem cell transplantation in high risk relapsed refractory classical Hodgkin lymphoma

Moussab Damlaj, Khadega A Abuelgasim, Ayman Alhejazi, Bader Alahmari, Ahmed Alaskar and Mohsen Alzahrani

Bone marrow transplantation (Basingstoke), Vol.55(12), pp.2322-2325

01/12/2020

DOI: https://doi.org/10.1038/s41409-020-0935-0

PMID: 32404976

Metrics

1 Record Views

See more details

Details

Title: Brentuximab vedotin containing salvage followed by consolidation post autologous hematopoietic stem cell transplantation in high risk relapsed refractory classical Hodgkin lymphoma
Creators - without role: Moussab Damlaj - King Abdulaziz Medical City
Khadega A Abuelgasim - King Saud bin Abdulaziz University for Health Sciences
Ayman Alhejazi - King Abdulaziz Medical City
Bader Alahmari - King Abdulaziz Medical City
Ahmed Alaskar - King Saud bin Abdulaziz University for Health Sciences
Mohsen Alzahrani - King Saud bin Abdulaziz University for Health Sciences
Publication Details: Bone marrow transplantation (Basingstoke), Vol.55(12), pp.2322-2325
Identifiers: 9921143208331
Academic Unit: King Abdulaziz University; King Saud Bin Abdulaziz University for Health Sciences
Language: English
Resource Type: Journal article